Viewing Study NCT06264557



Ignite Creation Date: 2024-05-06 @ 8:07 PM
Last Modification Date: 2024-10-26 @ 3:21 PM
Study NCT ID: NCT06264557
Status: RECRUITING
Last Update Posted: 2024-02-20
First Post: 2024-02-08

Brief Title: Cognitive Therapy Software for Improving Cognitive Function for Patients With Mild Cognitive Impairment
Sponsor: Rowan
Organization: Rowan

Study Overview

Official Title: A Multicenter Prospective Comparative Randomized Independent Rater-blind Superiority Clinical Trial to Compare the Safety and Efficacy of the Cognitive Therapy Software SUPERBRAIN DEX With a Control Group for Patients With MCI
Status: RECRUITING
Status Verified Date: 2024-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SB-DEX
Brief Summary: Cognitive therapy software for improving cognitive function for patients with mild cognitive impairment
Detailed Description: A multicenter prospective comparative randomized independent rater-blind superiority pivotal clinical trial to compare the safety and efficacy of the Cognitive therapy software SUPERBRAIN DEX for improving cognitive function with a control group for patients with mild cognitive impairment

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
ROWAN OTHER ROWAN None